Skip to main content
Signal8
Spangler Patrick D profile photo

Patrick D. Spangler

CIK: 0001296525

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OptimizeRx Corp logo
OPRX

OptimizeRx Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • OptimizeRx Corp logo
    OPRX

    OptimizeRx Corp

    Jun 9, 2026
    Award(A)
    Direct
    34.5K shares-
  • OptimizeRx Corp logo
    OPRX

    OptimizeRx Corp

    Aug 28, 2025
    Sale(S)
    Direct
    11.1K shares at avg. $17.49$194K
  • OptimizeRx Corp logo
    OPRX

    OptimizeRx Corp

    Jun 11, 2025
    Award(A)
    Direct
    9.9K shares-

1-3 of 3

About Spangler Patrick D

Spangler Patrick D (SEC CIK 0001296525) files insider reports with the SEC as Director of OptimizeRx Corp (OPRX).

Signal8 holds 3 ownership filings by Spangler Patrick D, all Form 4s, filed between Jun 12, 2025 and Jun 10, 2026. Those filings report 3 transactions, from Jun 11, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Spangler Patrick D's filings is in WALTHAM, MA.

Recent filings by Spangler Patrick D

  • Jun 9, 2026: Grant or award of OPRX shares (Form 4, code A).
  • Aug 28, 2025: Open-market sale of OPRX shares (Form 4, code S).
  • Jun 11, 2025: Grant or award of OPRX shares (Form 4, code A).

Other insiders filing for OptimizeRx Corp (OPRX)

How to read Form 4 transaction codes